MENU

HOLX Stock Hologic (HOLX, $65.85) was a top quarterly gainer, rising +15.2%

A.I.dvisor
at Tickeron.com
Loading...
HOLX - Hologic
Tickeron

Loading...

Price: $65.85
Daily change: +$0.95 (+1.46%)
Daily volume: 2.1M
3-month price change: +$8.69 (+15.2%)
Capitalization: $14.7B
Industry: Medical Specialties
Hologic (HOLX, $65.85) was one of top quarterly gainers, jumping to $65.85 per share. A.I.dvisor analyzed 392 stocks in the Medical Specialties Industry over the last three months, and discovered that of them (7) charted an Uptrend while of them (2) trended down.

Momentum Indicator for HOLX turns positive, indicating new upward trend

HOLX saw its Momentum Indicator move above the 0 level on July 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for HOLX just turned positive on July 31, 2025. Looking at past instances where HOLX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOLX advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

HOLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 221 cases where HOLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HOLX moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where HOLX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.839) is normal, around the industry mean (24.533). P/E Ratio (36.076) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (1.425) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.728) is also within normal values, averaging (43.112).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

View a ticker or compare two or three
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of diagnostics products, medical imaging systems and surgical products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
250 Campus Drive
Phone
+1 508 263-2900
Employees
6990
Web
http://www.hologic.com